Association between blood lead and the risk of amyotrophic lateral sclerosis

American Journal of Epidemiology

Volumn 171, Issue 10, 2010, Pages 1126-1133

  Fang, Fang ^a,b   Kwee, Lydia C ^c,d   Allen, Kelli D ^c,d   Umbach, David M ^a   Ye, Weimin ^b   Watson, Mary ^e   Keller, Jean ^f   Oddone, Eugene Z ^d   Sandler, Dale P ^a   Schmidt, Silke ^c,d   Kamel, Freya ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d DURHAM VA MEDICAL CENTER   (United States)

^e SOCIAL AND SCIENTIFIC SYSTEMS INC   (United States)

^f WESTAT   (United States)

Author keywords

Amyotrophic lateral sclerosis; Bone and bones; Bone resorption; Lead; Odds ratio; Osteogenesis

Indexed keywords

AMINO TERMINAL TELOPEPTIDE; ASPARAGINE; BIOLOGICAL MARKER; CARBOXY TERMINAL TELOPEPTIDE; LEAD; LYSINE; PORPHOBILINOGEN SYNTHASE; PROCOLLAGEN TYPE 1 AMINO TERMINAL PEPTIDE; UNCLASSIFIED DRUG;

BIOMARKER; BLOOD; BONE; CONFIDENCE INTERVAL; HEALTH RISK; LEAD; NERVOUS SYSTEM DISORDER; OSTEOLOGY; REGRESSION ANALYSIS; RESORPTION; RISK FACTOR;

ADULT; AGE DISTRIBUTION; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BLOOD SAMPLING; BONE TURNOVER; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE IDENTIFICATION; GENETIC ASSOCIATION; HEREDITY; HUMAN; LEAD BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OSSIFICATION; OSTEOLYSIS; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; TOXICOKINETICS; UNITED STATES; VETERAN;

ADULT; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; BIOLOGICAL MARKERS; BONE AND BONES; BONE RESORPTION; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; LEAD; LEAD POISONING; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; OSTEOGENESIS; PORPHOBILINOGEN SYNTHASE; QUESTIONNAIRES; REGISTRIES; RISK FACTORS; UNITED STATES; VETERANS;

UNITED STATES;

EID: 77952400682     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwq063     Document Type: Article

References (34)

1. Kamel F, Umbach DM, Hu H, et al. Lead exposure as a risk factor for amyotrophic lateral sclerosis. Neurodegener Dis. 2005;2(3-4):195-201.
2. Deapen DM, Henderson BE. A case-control study of amyotro-phic lateral sclerosis. Am J Epidemiol. 1986;123(5):790-799.
3. McGuire V, Longstreth WT Jr, Nelson LM, et al. Occupational exposures and amyotrophic lateral sclerosis. A population-based case-control study. Am J Epidemiol. 1997;145(12): 1076-1088.
4. Gunnarsson LG, Bodin L, Söderfeldt B, et al. A case-control study of motor neurone disease: its relation to heritability, and occupational exposures, particularly to solvents. Br J Ind Med. 1992;49(11):791-798.
5. Campbell AM, Williams ER, Barltrop D. Motor neurone disease and exposure to lead. J Neurol Neurosurg Psychiatry. 1970;33(6):877-885.
6. Felmus MT, Patten BM, Swanke L. Antecedent events in amyotrophic lateral sclerosis. Neurology. 1976;26(2):167-172.
7. Pierce-Ruhland R, Patten BM. Repeat study of antecedent events in motor neuron disease. Ann Clin Res. 1981;13(2):102-107.
8. Gresham LS, Molgaard CA, Golbeck AL, et al. Amyotrophic lateral sclerosis and occupational heavy metal exposure: a case-control study. Neuroepidemiology. 1986;5(1):29-38.
9. Armon C, Kurland LT, Daube JR, et al. Epidemiologic corre lates of sporadic amyotrophic lateral sclerosis. Neurology. 1991;41(7):1077-1084.
10. Chancellor AM, Slattery JM, Fraser H, et al. Risk factors for motor neuron disease: a case-control study based on patients from the Scottish Motor Neuron Disease Register. J Neurol Neurosurg Psychiatry. 1993;56(11):1200-1206. (Pubitemid 23323660)
11. Kamel F, Umbach DM, Lehman TA, et al. Amyotrophic lateral sclerosis, lead, and genetic susceptibility: polymorphisms in the delta-aminolevulinic acid dehydratase and vitamin D receptor genes. Environ Health Perspect. 2003;111(10):1335-1339.
12. Kamel F, Umbach DM, Munsat TL, et al. Lead exposure and amyotrophic lateral sclerosis. Epidemiology. 2002;13(3): 311-319.
13. Albers K, Nelson L, Tanner C, et al. Lead exposure and amyotrophic lateral sclerosis in a Northern California population [abstract]. Neuroepidemiology. 2009;33:74.
14. Hu H, Payton M, Korrick S, et al. Determinants of bone and blood lead levels among community-exposed middle-aged to elderly men. The Normative Aging Study. Am J Epidemiol. 1996;144(8):749-759.
15. Kelada SN, Shelton E, Kaufmann RB, et al. Delta-aminolevulinic acid dehydratase genotype and lead toxicity: a HuGE review. Am J Epidemiol. 2001;154(1):1-13.
16. Allen KD, Kasarskis EJ, Bedlack RS, et al. The National Registry of Veterans with Amyotrophic Lateral Sclerosis. Neuroepidemiology. 2008;30(3):180-190.
17. Brooks BR, Miller RG, Swash M, et al. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1(5):293-299.
18. Schmidt S, Allen KD, Loiacono VT, et al. Genes and Environmental Exposures in Veterans with Amyotrophic Lateral Sclerosis: the GENEVA study. Rationale, study design and demographic characteristics. Neuroepidemiology. 2008;30(3): 191-204.
19. Hansen TV, Simonsen MK, Nielsen FC, et al. Collection of blood, saliva, and buccal cell samples in a pilot study on the Danish nurse cohort: comparison of the response rate and quality of genomic DNA. Cancer Epidemiol Biomarkers Prev. 2007;16(10):2072-2076.
20. Rylander-Rudqvist T, Hakansson N, Tybring G, et al. Quality and quantity of saliva DNA obtained from the self-administrated oragene method\a pilot study on the cohort of Swedish men. Cancer Epidemiol Biomarkers Prev. 2006;15(9):1742-1745.
21. Kamel F, Umbach DM, Munsat TL, et al. Association of cigarette smoking with amyotrophic lateral sclerosis. Neuro-epidemiology. 1999;18(4):194-202.
22. Weisskopf MG, McCullough ML, Calle EE, et al. Prospective study of cigarette smoking and amyotrophic lateral sclerosis. Am J Epidemiol. 2004;160(1):26-33.
23. Nelson LM, McGuire V, Longstreth WT Jr, et al. Population-based case-control study of amyotrophic lateral sclerosis in western Washington State. I. Cigarette smoking and alcohol consumption. Am J Epidemiol. 2000;151(2):156-163. (Pubitemid 30463646)
24. Rothstein JD. Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann Neurol. 2009;65(suppl 1): S3-S9.
25. Bondy SC, Komulainen H. Intracellular calcium as an index of neurotoxic damage. Toxicology. 1988;49(1):35-41.
26. Adonaylo VN, Oteiza PI. Lead intoxication: antioxidant defenses and oxidative damage in rat brain. Toxicology. 1999; 135(2-3):77-85.
27. Savolainen KM, Loikkanen J, Eerikäinen S, et al. Interactions of excitatory neurotransmitters and xenobiotics in excitotoxicity and oxidative stress: glutamate and lead. Toxicol Lett. 1998;102-103:363-367.
28. Mancuso JD, McCoy J, Pelka B, et al. The challenge of controlling lead and silica exposures from firing ranges in a special operations force. Mil Med. 2008;173(2):182-186.
29. Horner RD, Kamins KG, Feussner JR, et al. Occurrence of amyotrophic lateral sclerosis among Gulf War veterans. Neurology. 2003;61(6):742-749.
30. Haley RW. Excess incidence of ALS in young Gulf War veterans. Neurology. 2003;61(6):750-756.
31. Coffman CJ, Horner RD, Grambow SC, et al. Estimating the occurrence of amyotrophic lateral sclerosis among Gulf War (1990-1991) veterans using capture-recapture methods. Neuroepidemiology. 2005;24(3):141-150.
32. Weisskopf MG, O'Reilly EJ, McCullough ML, et al. Prospective study of military service and mortality from ALS. Neurology. 2005;64(1):32-37.
33. Hu H, Wu MT, Cheng Y, et al. The delta-aminolevulinic acid dehydratase (ALAD) polymorphism and bone and blood lead levels in community-exposed men: the Normative Aging Study. Environ Health Perspect. 2001;109(8): 827-832.
34. Onalaja AO, Claudio L. Genetic susceptibility to lead poisoning. Environ Health Perspect. 2000;108(suppl 1):23-28.